WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IONS

Based on 16 analysts offering 12 month price targets for Ionis Pharmaceuticals Inc

Min Forecast
$75.00+31.03%
Avg Forecast
$97.13+69.68%
Max Forecast
$129.00+125.37%

Should I buy or sell IONS stock?

Based on 18 analysts offering ratings for Ionis Pharmaceuticals Inc.

Strong Buy
Strong Buy
11 analysts 61.11%
Buy
4 analysts 22.22%
Hold
3 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IONS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IONS as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their IONS stock forecasts and price targets.

IONS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-03Find Out Why
lockedlocked$00.00+00.00%2026-07-30
lockedlocked$00.00+00.00%2026-07-30
lockedlocked$00.00+00.00%2026-07-21
lockedlocked$00.00+00.00%2026-07-16
RBC Capital
Top 11%
90
BuyMaintains$85.00+48.50%2026-07-13
Morgan Stanley
Top 14%
87
Strong BuyMaintains$110.00+92.17%2026-07-10
Barclays
Top 12%
89
Strong BuyMaintains$90.00+57.23%2026-07-10
Canaccord Genuity
Top 37%
64
Strong BuyMaintains$95.00+65.97%2026-07-10
Citigroup
Bottom 9%
9
Strong BuyMaintains$100.00+74.70%2026-07-10

1 of 2

Forecast return on equity

Is IONS forecast to generate an efficient return?

Company
209.99%
Industry
46.64%
Market
167.85%
IONS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IONS forecast to generate an efficient return on assets?

Company
30.84%
Industry
37.35%
IONS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IONS earnings per share forecast

What is IONS's earnings per share in the next 3 years based on estimates from 26 analysts?

Avg 1 year Forecast
-$3.71
Avg 2 year Forecast
-$2.16
Avg 3 year Forecast
$0.72

IONS revenue forecast

What is IONS's revenue in the next 3 years based on estimates from 27 analysts?

Avg 1 year Forecast
$936.6M+7.16%
Avg 2 year Forecast
$1.4B+65.54%
Avg 3 year Forecast
$2.1B+139.11%
IONS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IONS revenue growth forecast

How is IONS forecast to perform vs Biotechnology companies and vs the US market?

Company
33.18%
Industry
32.03%
Market
13.48%
IONS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IONS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IONS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IONS$57.24$97.13+69.68%Strong Buy
ABVX$118.96$154.22+29.64%Strong Buy
KYMR$117.39$128.40+9.38%Strong Buy
KRYS$332.27$358.22+7.81%Strong Buy
SYRE$103.63$109.39+5.55%Strong Buy
View Top Biotech Stocks

Ionis Pharmaceuticals Stock Forecast FAQ

Is Ionis Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 18 Wall Street analysts covering (NASDAQ: IONS) stock is to Strong Buy IONS stock.

Out of 18 analysts, 11 (61.11%) are recommending IONS as a Strong Buy, 4 (22.22%) are recommending IONS as a Buy, 3 (16.67%) are recommending IONS as a Hold, 0 (0%) are recommending IONS as a Sell, and 0 (0%) are recommending IONS as a Strong Sell.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.

What is IONS's earnings growth forecast for 2026-2028?

(NASDAQ: IONS) Ionis Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.68%.

Ionis Pharmaceuticals's earnings in 2026 is -$565,174,000.On average, 26 Wall Street analysts forecast IONS's earnings for 2026 to be -$617,208,572, with the lowest IONS earnings forecast at -$657,956,968, and the highest IONS earnings forecast at -$542,674,903. On average, 25 Wall Street analysts forecast IONS's earnings for 2027 to be -$358,409,727, with the lowest IONS earnings forecast at -$599,327,139, and the highest IONS earnings forecast at -$115,165,735.

In 2028, IONS is forecast to generate $119,769,041 in earnings, with the lowest earnings forecast at -$429,952,078 and the highest earnings forecast at $584,553,353.

What is IONS's revenue growth forecast for 2026-2028?

(NASDAQ: IONS) Ionis Pharmaceuticals's forecast annual revenue growth rate of 33.18% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.48%.

Ionis Pharmaceuticals's revenue in 2026 is $874,089,000.On average, 27 Wall Street analysts forecast IONS's revenue for 2026 to be $155,654,883,358, with the lowest IONS revenue forecast at $142,042,725,543, and the highest IONS revenue forecast at $172,166,957,592. On average, 27 Wall Street analysts forecast IONS's revenue for 2027 to be $240,468,713,934, with the lowest IONS revenue forecast at $191,610,523,266, and the highest IONS revenue forecast at $363,943,665,180.

In 2028, IONS is forecast to generate $347,325,232,980 in revenue, with the lowest revenue forecast at $269,717,154,606 and the highest revenue forecast at $451,024,249,908.

What is IONS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: IONS) forecast ROA is 30.84%, which is lower than the forecast US Biotechnology industry average of 37.35%.

What is IONS's Price Target?

According to 16 Wall Street analysts that have issued a 1 year IONS price target, the average IONS price target is $97.13, with the highest IONS stock price forecast at $129.00 and the lowest IONS stock price forecast at $75.00.

On average, Wall Street analysts predict that Ionis Pharmaceuticals's share price could reach $97.13 by Aug 3, 2027. The average Ionis Pharmaceuticals stock price prediction forecasts a potential upside of 69.68% from the current IONS share price of $57.24.

What is IONS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IONS) Ionis Pharmaceuticals's current Earnings Per Share (EPS) is -$3.48. On average, analysts forecast that IONS's EPS will be -$3.71 for 2026, with the lowest EPS forecast at -$3.96, and the highest EPS forecast at -$3.27. On average, analysts forecast that IONS's EPS will be -$2.16 for 2027, with the lowest EPS forecast at -$3.61, and the highest EPS forecast at -$0.69. In 2028, IONS's EPS is forecast to hit $0.72 (min: -$2.59, max: $3.52).

What is IONS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: IONS) forecast ROE is 209.99%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.